Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Time Factors. Found 108 abstracts

no pagination
Battistuzzi FU, Tao Q, Jones L, Tamura K, Kumar S. RelTime Relaxes the Strict Molecular Clock throughout the Phylogeny. Genome biology and evolution. 2018 Jun;10(6):1631-6.   PMCID: PMC6022624
Geynisman DM, Meeker CR, Doyle JL, Handorf EA, Bilusic M, Plimack ER, Wong YN. Provider and patient burdens of obtaining oral anticancer medications. The American journal of managed care. 2018 Apr;24(4):e128-e133.
Harshman LC, Chen YH, Liu G, Carducci MA, Jarrard D, Dreicer R, Hahn N, Garcia JA, Hussain M, Shevrin D, Eisenberger M, Kohli M, Plimack ER, Cooney M, Vogelzang NJ, Picus J, Dipaola R, Sweeney CJ. Seven-Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation With or Without Docetaxel. J Clin Oncol. 2018 Feb;36(4):376-82.   PMCID: PMC5805480
Joshi SS, Handorf EA, Zibelman M, Plimack ER, Uzzo RG, Kutikov A, Smaldone MC, Geynisman DM. Treatment Facility Volume and Survival in Patients with Metastatic Renal Cell Carcinoma: A Registry-based Analysis. Eur Urol. 2018 Sep;74(3):387-93.
Kyriakopoulos CE, Chen YH, Carducci MA, Liu G, Jarrard DF, Hahn NM, Shevrin DH, Dreicer R, Hussain M, Eisenberger M, Kohli M, Plimack ER, Vogelzang NJ, Picus J, Cooney MM, Garcia JA, DiPaola RS, Sweeney CJ. Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial. J Clin Oncol. 2018 Apr 10;36(11):1080-7.   PMCID: PMC5891129
Roach M, Moughan J, Lawton CA, Dicker AP, Zeitzer KL, Gore EM, Kwok Y, Seider MJ, Hsu IC, Hartford AC, Horwitz EM, Yamoah K, Jones CU, Michalski JM, Lee WR, Pisansky TM, Rabinovitch R, Rotman M, Pryzant RM, Kim HE, Thomas CR, Shipley WU, Sandler HM. Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial. Lancet Oncol. 2018 Nov;19(11):1504-15.   PMCID: PMC6540797
Tahrir FG, Shanmughapriya S, Ahooyi TM, Knezevic T, Gupta MK, Kontos CD, McClung JM, Madesh M, Gordon J, Feldman AM, Cheung JY, Khalili K. Dysregulation of mitochondrial bioenergetics and quality control by HIV-1 Tat in cardiomyocytes. Journal of cellular physiology. 2018 Feb;233(2):748-58.   PMCID: PMC5673531
Tahrir FG, Shanmughapriya S, Ahooyi TM, Knezevic T, Gupta MK, Kontos CD, McClung JM, Madesh M, Gordon J, Feldman AM, Cheung JY, Khalili K. Dysregulation of mitochondrial bioenergetics and quality control by HIV-1 Tat in cardiomyocytes. Journal of cellular physiology. 2018 Feb;233(2):748-58.   PMCID: PMC5673531
Chambers SK, Occhipinti S, Foley E, Clutton S, Legg M, Berry M, Stockler MR, Frydenberg M, Gardiner RA, Lepore SJ, Davis ID, Smith DP. Mindfulness-Based Cognitive Therapy in Advanced Prostate Cancer: A Randomized Controlled Trial. J Clin Oncol. 2017 Jan 20;35(3):291-7.
Dong Z, Shanmughapriya S, Tomar D, Siddiqui N, Lynch S, Nemani N, Breves SL, Zhang X, Tripathi A, Palaniappan P, Riitano MF, Worth AM, Seelam A, Carvalho E, Subbiah R, Jana F, Soboloff J, Peng Y, Cheung JY, Joseph SK, Caplan J, Rajan S, Stathopulos PB, Madesh M. Mitochondrial Ca(2+) Uniporter Is a Mitochondrial Luminal Redox Sensor that Augments MCU Channel Activity. Molecular cell. 2017 Mar 16;65(6):1014-1028e7.   PMCID: PMC5357178
Fan F, Yuan Z, Qin X, Li J, Zhang Y, Li Y, Yu T, Ji M, Ge J, Zheng M, Yang X, Bao H, Cheng X, Gu D, Zhao D, Wang J, Sun N, Chen Y, Wang H, Wang X, Parati G, Hou F, Xu X, Wang X, Zhao G, Huo Y. Optimal Systolic Blood Pressure Levels for Primary Prevention of Stroke in General Hypertensive Adults: Findings From the CSPPT (China Stroke Primary Prevention Trial). Hypertension (Dallas, Tex : 1979). 2017 Apr;69(4):697-704.
Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos-Blom MJ, Jervis S, van Leeuwen FE, Milne RL, Andrieu N, Goldgar DE, Terry MB, Rookus MA, Easton DF, Antoniou AC, Brca, Brca Cohort Consortium, McGuffog L, Evans DG, Barrowdale D, Frost D, Adlard J, Ong KR, Izatt L, Tischkowitz M, Eeles R, Davidson R, Hodgson S, Ellis S, Nogues C, Lasset C, Stoppa-Lyonnet D, Fricker JP, Faivre L, Berthet P, Hooning MJ, van der Kolk LE, Kets CM, Adank MA, John EM, Chung WK, Andrulis IL, Southey M, Daly MB, Buys SS, Osorio A, Engel C, Kast K, Schmutzler RK, Caldes T, Jakubowska A, Simard J, Friedlander ML, McLachlan SA, Machackova E, Foretova L, Tan YY, Singer CF, Olah E, Gerdes AM, Arver B, Olsson H. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers. Jama. 2017 Jun 20;317(23):2402-16.
Lawton CA, Lin X, Hanks GE, Lepor H, Grignon DJ, Brereton HD, Bedi M, Rosenthal SA, Zeitzer KL, Venkatesan VM, Horwitz EM, Pisansky TM, Kim H, Parliament MB, Rabinovitch R, Roach M, Kwok Y, Dignam JJ, Sandler HM. Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of NRG Oncology RTOG 9202. Int J Radiat Oncol Biol Phys. 2017 Jun;98(2):296-303.   PMCID: PMC5603177
Mirhadi AJ, Zhang Q, Hanks GE, Lepor H, Grignon DJ, Peters CA, Rosenthal SA, Zeitzer K, Radwan JS, Lawton C, Parliament MB, Reznik RS, Sandler HM. Effect of Long-Term Hormonal Therapy (vs Short-Term Hormonal Therapy): A Secondary Analysis of Intermediate-Risk Prostate Cancer Patients Treated on NRG Oncology RTOG 9202. Int J Radiat Oncol Biol Phys. 2017 Mar;97(3):511-5.   PMCID: PMC5485922
Muffly L, Pasquini MC, Martens M, Brazauskas R, Zhu X, Adekola K, Aljurf M, Ballen KK, Bajel A, Baron F, Battiwalla M, Beitinjaneh A, Cahn JY, Carabasi M, Chen YB, Chhabra S, Ciurea S, Copelan E, D'Souza A, Edwards J, Foran J, Freytes CO, Fung HC, Gale RP, Giralt S, Hashmi SK, Hildebrandt GC, Ho V, Jakubowski A, Lazarus H, Luskin MR, Martino R, Maziarz R, McCarthy P, Nishihori T, Olin R, Olsson RF, Pawarode A, Peres E, Rezvani AR, Rizzieri D, Savani BN, Schouten HC, Sabloff M, Seftel M, Seo S, Sorror ML, Szer J, Wirk BM, Wood WA, Artz A. Increasing use of allogeneic hematopoietic cell transplantation in patients age 70 years and older in the United States. Blood. 2017 Jul 03;130(9):1156-64.   PMCID: PMC5580273
Qin X, Li Y, Sun N, Wang H, Zhang Y, Wang J, Li J, Xu X, Liang M, Nie J, Wang B, Cheng X, Li N, Sun Y, Zhao L, Wang X, Hou FF, Huo Y. Elevated Homocysteine Concentrations Decrease the Antihypertensive Effect of Angiotensin-Converting Enzyme Inhibitors in Hypertensive Patients. Arteriosclerosis, thrombosis, and vascular biology. 2017 Jan;37(1):166-72.
Bleicher RJ, Ruth K, Sigurdson ER, Beck JR, Ross E, Wong YN, Patel SA, Boraas M, Chang EI, Topham NS, Egleston BL. Time to Surgery and Breast Cancer Survival in the United States. JAMA Oncol. 2016 Mar;2(3):330-9.   PMCID: 4788555
Bleicher RJ, Ruth K, Sigurdson ER, Beck JR, Ross E, Wong YN, Patel SA, Boraas M, Chang EI, Topham NS, Egleston BL. Time to Surgery and Breast Cancer Survival in the United States. JAMA Oncol. 2016 Mar;2(3):330-9.   PMCID: PMC4788555
Chang EI, Jenkins MP, Patel SA, Topham NS. Long-Term Operative Outcomes of Preoperative Computed Tomography-Guided Virtual Surgical Planning for Osteocutaneous Free Flap Mandible Reconstruction. Plast Reconstr Surg. 2016 Feb;137(2):619-23.
Chan JK, Java JJ, Fuh K, Monk BJ, Kapp DS, Herzog T, Bell J, Young R. The association between timing of initiation of adjuvant therapy and the survival of early stage ovarian cancer patients - An analysis of NRG Oncology/Gynecologic Oncology Group trials. Gynecol Oncol. 2016 Dec;143(3):490-5.   PMCID: PMC5728987
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Time Factors

Time Factors Aged Male Middle Aged Treatment Outcome Female mortality pathology drug therapy methods therapeutic use administration & dosage Prostatic Neoplasms 80 and over Aged Adult blood United States Retrospective Studies Androgen Antagonists therapy adverse effects Antineoplastic Combined Chemotherapy Protocols epidemiology Prostate-Specific Antigen Breast Neoplasms metabolism genetics Energy Metabolism drug effects Cell Hypoxia Survival Rate Adenocarcinoma Reactive Oxygen Species Calcium Channels diagnosis Cohort Studies Calcium Neoplasm Staging Kallikreins Primary Cell Culture Sprague-Dawley Rats physiopathology HIV-1 Tat mitochondrial bioenergetics Oral Administration hypoxia Double-Blind Method Combined Modality Therapy Survival Analysis Mitochondrial Degradation statistics & numerical data Kaplan-Meier Estimate Mutation Kidney Neoplasms Risk Factors Follow-Up Studies Prognosis Adenosine Triphosphate Male Breast Neoplasms Cardiac Myocytes Signal Transduction hypertension Risk Assessment surgery Hormone-Dependent Neoplasms Folic Acid Microtubule-Associated Proteins Multivariate Analysis Neoplasm Grading Drug Administration Schedule Disease-Free Survival Flutamide Oxidative Phosphorylation Membrane Potentials Sequestosome-1 Protein Blood Pressure Enalapril Heart Mitochondria Incidence Docetaxel virology HIV-1 cardiomyocytes Ovarian Neoplasms Host-Pathogen Interactions Goserelin Apoptosis Medicare Human Immunodeficiency Virus tat Gene Products Hypertension Neoplasm Metastasis Autophagy Angiotensin-Converting Enzyme Inhibitors Cultured Cells reoxygenation SEER Program China Primary Prevention Patient Education as Topic Structure-Activity Relationship homocysteine concentrations Psychological Adaptation goal blood pressure Cancer survival Group Psychotherapy Age Distribution Patient Care Planning HEK293 Cells Cell Death Combination Drug Therapy Adolescent Survival Homocysteine stroke Knockout Mice BRCA2 Genes Parenteral Infusions Cytoreduction Surgical Procedures Endothelial Cells Transfection radiotherapy Micu2 gluathionylation Stroke BRCA1 Genes Biomarkers Carboplatin Adjuvant Chemotherapy Antihypertensive Agents Cysteine Bayes Theorem Genetic Models Quality of Life physiology enalapril-based antihypertensive treatment Drug Dose-Response Relationship Computer-Assisted Surgery Mcu Free Tissue Flaps Calcium Signaling pharmacology chemistry Conformal Radiotherapy Glandular and Epithelial Neoplasms Thrombin Cognitive Therapy secondary Deductibles and Coinsurance Cercopithecus aethiops Mitochondrial Membranes
Last updated on Friday, December 06, 2019